OBJECTIVES: As a result of this activity, the participant should be able to:
1. Characterize the role of hope in the management of psychiatric patients
2. Describe novel treatments that are in development for treatment-resistant depression
3. Describe a consensus algorithm for management of treatment-resistant depression

FACULTY DISCLOSURE: Paul B. Hicks, MD, Ph.D. has no relevant financial relationships to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

PLANNERS DISCLOSURE:  Louis A. Gamino, PhD, ABPP, FT and Radha K. Kambhampati M.D., MPH, LFAPA, CPA have no relevant financial relationships to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NOTE:  ADD WEBEX/TEAMS Meeting Invitation link